中重度高磷血症是成人脓毒症患者28天死亡率的独立预后因素
该回顾性队列研究在韩国一家城市三级医院急诊科开展,纳入2010年3月至2017年4月就诊的3034例脓毒症患者,按急诊首次血磷浓度分为四组:低磷血症(<2 mg/dL)、正常磷血症(2-4 mg/dL)、轻度高磷血症(4-6 mg/dL)、中重度高磷血症(≥6 mg/dL)。总体死亡率为21.9%,四组28天死亡率分别为14.6%、17.4%、29.2%和51.4%(p<0.001)。多因素Cox回归显示,中重度高磷血症组较正常磷血症组死亡风险显著升高(HR 1.59;95%CI 1.23-2.05),其他组与正常磷组相比死亡率无显著差异。作者认为血磷水平可作为脓毒症预后指标。
要点
- 脓毒症患者急诊首次血磷≥6 mg/dL(中重度高磷血症)与28天死亡风险独立相关,HR 1.59(95%CI 1.23-2.05)。
- 四组28天死亡率:低磷组14.6%、正常磷组17.4%、轻度高磷组29.2%、中重度高磷组51.4%(p<0.001)。
- 低磷血症组(<2 mg/dL)和轻度高磷血症组(4-6 mg/dL)与正常磷组相比死亡率无显著差异。
- 3034例脓毒症患者总体28天死亡率为21.9%,中重度高磷血症组死亡率超过半数(51.4%)。
- 血磷水平可在急诊就诊时作为脓毒症预后评估的参考指标。
适用人群与场景
- 韩国一家城市三级医院急诊科就诊的成人脓毒症患者,就诊时间为2010年3月至2017年4月。
诊断标准与关键阈值
- 按急诊首次血磷浓度分组:低磷血症组<2 mg/dL,正常磷血症组2-4 mg/dL,轻度高磷血症组4-6 mg/dL,中重度高磷血症组≥6 mg/dL。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入3034例脓毒症患者,总体28天死亡率为21.9%。
- 28天死亡率:低磷血症组14.6%、正常磷血症组17.4%、轻度高磷血症组29.2%、中重度高磷血症组51.4%(p<0.001)。
- 多因素Cox回归显示,中重度高磷血症组较正常磷血症组28天死亡风险显著升高(HR 1.59;95%CI 1.23-2.05)。
- 低磷血症组和轻度高磷血症组与正常磷血症组相比死亡率无显著差异。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 急诊接诊脓毒症患者时,首次血磷≥6 mg/dL提示28天死亡风险较高(HR 1.59;95%CI 1.23-2.05),可辅助预后评估。
- 血磷2-6 mg/dL范围内(低磷及轻度高磷)与正常磷血症相比28天死亡率无显著差异,不据此单独调整预后判断。
- 作者认为血磷水平可作为脓毒症预后指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Ischaemic tissue injury caused by tissue hypoperfusion is one of the major consequences of sepsis. Phosphate concentrations are elevated in ischaemic tissue injury. This study was performed to investigate the association of phosphate concentrations with mortality in patients with sepsis.
METHODS: This was a retrospective cohort study of patients with sepsis conducted at an urban, tertiary care emergency department (ED) in Korea. Patients with sepsis arriving between March 2010 and April 2017 were stratified into four groups according to the initial phosphate concentration at presentation to the ED: group I (hypophosphataemia, phosphate <2 mg/dL), group II (normophosphataemia, phosphate 2-4 mg/dL), group III (mild hyperphosphataemia, phosphate 4-6 mg/dL), group IV (moderate to severe hyperphosphataemia, phosphate ≥6 mg/dL). Multivariable Cox proportional hazard regression analyses were performed to evaluate the independent association of initial phosphate concentration with 28-day mortality.
RESULTS: Of the 3034 participants in the study, the overall mortality rate was 21.9%. The 28-day mortality rates were group I (hypophosphataemia) 14.6%, group II 17.4% (normophosphataemia), group III (mild hyperphosphataemia) 29.2% and group IV (moderate to severe hyperphosphataemia) 51.4%, respectively (p<0.001). In the multivariable analyses, patients with severe hyperphosphataemia had a significantly higher risk of death than those with normal phosphate levels (HR 1.59; 95% CI 1.23 to 2.05). Mortality in the other groups was not significantly different from mortality in patients with normophosphataemia.
CONCLUSIONS: Moderate to severe hyperphosphataemia was associated with 28-day mortality in patients with sepsis. Phosphate level could be used as a prognostic indicator in sepsis.
参考来源
- Jang DH, Jo YH, Lee JH, et al. Moderate to severe hyperphosphataemia as an independent prognostic factor for 28-day mortality in adult patients with sepsis. Emerg Med J. 2020. PMID: 32321706. doi:10.1136/emermed-2019-208976
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。